Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner - unknown - afoxolaner active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - ectoparasiticides for systemic use - dogs - treatment of flea (ctenocephalides felis and c. canis) infestations. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). treatment of tick (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) infestations. treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).,

United States - English - NLM (National Library of Medicine)

frontline vet labs - afoxolaner (unii: 02l07h6d0u) (afoxolaner - unii:02l07h6d0u) - afoxolaner 11.3 mg - nexgard kills adult fleas and is indicated for the treatment and prevention of flea infestations (ctenocephalides felis) , and the treatment and control of black-legged tick (ixodes scapularis) , american dog tick (dermacentor variabilis) , lone star tick (amblyomma americanum), and brown dog tick (rhipicephalus sanguineus) infestations in dogs and puppies 8 weeks of age and older, weighing 4 pounds of body weight or greater, for one month. nexgard is indicated for the prevention of borrelia burgdorferi infections as a direct result of killing lxodes scapularis vector ticks. there are no known contraindications for the use of nexgard.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - esafoxolaner - unknown - esafoxolaner active active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 9.4 mg/chew; milbemycin oxime antibiotic active 1.9 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 18.8 mg/chew; milbemycin oxime antibiotic active 3.8 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 37.5 mg/chew; milbemycin oxime antibiotic active 7.5 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 150.0 mg/chew; milbemycin oxime antibiotic active 30.0 mg/chew - parasiticides

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - afoxolaner - afoxolaner 22.67 g/kg - ectoparasiticide

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.